Medplus Health Servi
Ticker >

Medplus Health Servi share price

Medplus Health Services Ltd.

NSE: MEDPLUS BSE: 543427 SECTOR: Pharmaceuticals & Drugs  137k   69   23

680.45
-2.85 (-0.42%)
NSE: 25 Apr 04:03 PM

Price Summary

Today's High

₹ 691.95

Today's Low

₹ 676.05

52 Week High

₹ 978

52 Week Low

₹ 598.6

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 8133.89 Cr.

Enterprise Value

₹ 8043.73 Cr.

No. of Shares

11.95 Cr.

P/E

1514.13

P/B

7.03

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  96.77

CASH

₹ 90.16 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

40.39 %

EPS (TTM)

₹  0.45

Sales Growth

46.81%

ROE

0.5 %

ROCE

1.25%

Profit Growth

-0.63 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year46.81%
3 Year51.84%
5 Year86.73%

Profit Growth

1 Year-0.63%
3 Year30.51%
5 Year18.56%

ROE%

1 Year0.5%
3 Year-0.26%
5 Year-2.21%

ROCE %

1 Year1.25%
3 Year0.17%
5 Year-1.83%

Debt/Equity

0

Price to Cash Flow

713.19

Interest Cover Ratio

2.15905271199389

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 40.39 54.17
Dec 2023 40.45 58.05
Sep 2023 40.41 50.53
Jun 2023 40.43 50.53
Mar 2023 40.43 50.53
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 30.5085275421313% for the Past 3 years.
  • The company has shown a good revenue growth of 51.8360307340647% for the Past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 33.6196746499516 days.
  • Company has a healthy liquidity position with current ratio of 3.13625192652143.

 Limitations

  • Company has a poor ROE of -0.263476653866618% over the past 3 years.
  • Company has a poor ROCE of 0.169431363838037% over the past 3 years
  • The company has a low EBITDA margin of -16.9721214019598% over the past 5 years.
  • The company is trading at a high PE of 1514.13.
  • The company is trading at a high EV/EBITDA of 207.7422.
  • Promoter pledging is high as 54.17%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 57.24 86.95 71.89 98.67 148.1
Total Expenditure 53.5 75.53 69.57 92.4 137.31
Operating Profit 3.74 11.42 2.32 6.27 10.79
Other Income 4.07 2.54 1.81 1.77 1.82
Interest 1.79 2.05 2.08 2.11 2.1
Depreciation 4.24 5.33 5.54 5.97 6.27
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.78 6.59 -3.49 -0.04 4.24
Tax 1.16 0.88 0 0 1.05
Profit After Tax 0.62 5.71 -3.49 -0.04 3.19
Adjusted EPS (Rs) 0.05 0.48 -0.29 0 0.27

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 9.52 61.11 68.31 145.71 213.93
Total Expenditure 12.99 86.29 77.11 142.41 207.67
Operating Profit -3.47 -25.18 -8.8 3.3 6.26
Other Income 1.03 1.92 2.11 9.54 23.18
Interest 0 0.27 0.57 2.63 6.55
Depreciation 0.13 0.84 1.32 4.63 15.31
Exceptional Items 0 0 0 0 0
Profit Before Tax -2.57 -24.36 -8.57 5.58 7.59
Tax 0 0.51 0 0 2.04
Net Profit -2.57 -24.87 -8.57 5.58 5.54
Adjusted EPS (Rs.) -11.77 -113.97 -38.25 0.47 0.46

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 0.19 0.19 0.45 23.86 23.86
Total Reserves 185.01 395.41 517.03 1088.92 1117.42
Borrowings 0 0 0 0 0
Other N/C liabilities 0.13 3.96 7.34 42.4 84.69
Current liabilities 6.17 16.17 23.6 32.28 48.01
Total Liabilities 191.51 415.74 548.42 1187.45 1273.99
Assets
Net Block 0.15 7.17 22.68 85.02 179.41
Capital WIP 0 0.95 2.01 15.52 17.91
Intangible WIP 0 0 0 0 0
Investments 186.03 381.09 408.5 418.45 917.16
Loans & Advances 2.39 1.63 8.75 11.13 8.92
Other N/C Assets 0.03 0 0 0 0
Current Assets 2.93 24.9 106.49 657.34 150.58
Total Assets 191.51 415.74 548.42 1187.45 1273.99
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations -2.57 -24.36 -8.57 5.58 7.59
Adjustment 0.32 31.25 8.22 0.65 3.39
Changes in Assets & Liabilities 1.26 -4.79 -6.17 -22.59 2.24
Tax Paid 0.06 0.79 0.28 -2.01 -1.81
Operating Cash Flow -0.93 2.89 -6.24 -18.37 11.41
Investing Cash Flow -2.81 -196.64 -14.77 -635.99 31.72
Financing Cash Flow 0 203.96 96.94 568.63 -8.36
Net Cash Flow -3.74 10.21 75.94 -85.74 34.77

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 40.43 40.43 40.41 40.45 40.39
agilemed investments pvt ... 13.12 13.12 13.11 - 13.09
lone furrow investments p... 14.44 14.44 14.44 14.48 14.46
madhukar reddy gangadi 12.87 12.87 12.86 12.86 12.84
agilemed investments priv... - - - 13.11 -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 59.57 59.57 59.59 59.55 59.61
arisaig asia fund limited... - - - - 1.93
fidelity funds - india fo... - - 1.39 1.50 1.50
goldman sachs funds - gol... - - - - 1.03
government of singapore - - 1.51 2.24 1.83
lavender rose investment ... 17.24 17.24 11.36 11.36 11.35
nippon life india trustee... - - 6.97 - 6.97
pi opportunities fund i 14.11 14.11 8.24 8.24 8.23
pravesa holding private l... 1.52 1.52 1.52 1.52 1.51
sbi focused equity fund - - 6.63 6.63 5.20
steadview capital maurit... - - 1.71 1.71 1.72
nippon life india trustee... - - - 6.98 -
nippon life india trustee... 3.05 3.63 - - -
sbi healthcare opportunit... - 6.87 - - -
sbi life insurance co. lt... 1.32 1.07 - - -
sbi nifty smallcap 250 in... 7.39 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

  • ConcallQ4FY22 21 Jun 2022
  • PresentationQ4FY23 26 May 2023
  • PresentationQ3FY24 5 Feb 2024
  • PresentationQ3FY22 17 Feb 2022
  • PresentationQ2FY23 11 Nov 2022

Company News

Medplus Health Services informs about revised disclosure26 Mar 2024, 12:20PM Medplus Health Services informs about revised disclosure26 Mar 2024, 12:19PM Medplus Health Services informs about revised disclosure 23 Mar 2024, 12:36PM Medplus Health Services informs about disclosures23 Mar 2024, 11:54AM Medplus Health Services informs about analyst meet6 Mar 2024, 1:01PM Medplus Health Services informs about disclosure2 Mar 2024, 12:00PM Medplus Health Services informs about outcome of board meeting 21 Feb 2024, 2:45PM Medplus Health Services informs about disclosures17 Feb 2024, 12:28PM Medplus Health Services informs about disclosures 17 Feb 2024, 12:28PM Medplus Health Services informs about disclosure 17 Feb 2024, 11:48AM Medplus Health Services informs about disclosure12 Feb 2024, 10:14AM Medplus Health Services informs about disclosure 12 Feb 2024, 10:13AM Medplus Health Servi - Quaterly Results2 Feb 2024, 5:33PM Medplus Health Servi - Quaterly Results2 Feb 2024, 5:33PM Medplus Health Servi - Quaterly Results2 Feb 2024, 5:33PM Medplus Health services informs about disclosure 16 Jan 2024, 4:34PM Medplus Health Services informs about disclosures2 Jan 2024, 5:44PM Medplus Health Services informs about analyst meet6 Dec 2023, 4:51PM Medplus Health Services informs about investor meetings29 Nov 2023, 5:21PM Medplus Health Services informs about order from drugs and control authority29 Nov 2023, 5:16PM Medplus Health Servi - Quaterly Results8 Nov 2023, 4:56PM Medplus Health Servi - Quaterly Results8 Nov 2023, 4:56PM Medplus Health Services informs about board meeting 9 Oct 2023, 2:46PM MedPlus Health Services informs about closure trading window 30 Sep 2023, 3:38PM Two entities sell shares worth Rs 1,206 crore of Medplus Health Services1 Sep 2023, 11:08AM Medplus Health Services informs about disclosure28 Aug 2023, 4:23PM Medplus Health Services informs about disclosure11 Aug 2023, 12:14PM Medplus Health Servi - Quaterly Results7 Aug 2023, 6:31PM Medplus Health Servi - Quaterly Results7 Aug 2023, 6:31PM MedPlus Health Services to sell over 500 off-patent medicines with massive discount21 Jun 2023, 6:09PM Medplus Health Services informs about analyst meet16 Jun 2023, 2:08PM Medplus Health Servi - Quaterly Results25 May 2023, 4:34PM Medplus Health Servi - Quaterly Results25 May 2023, 4:34PM Medplus Health Servi - Quaterly Results25 May 2023, 4:34PM Medplus Health Services informs about postal ballot notice20 May 2023, 12:40PM Medplus Health Servi - Quaterly Results3 Feb 2023, 6:05PM Medplus Health Servi - Quaterly Results3 Feb 2023, 6:05PM Medplus Health Servi - Quaterly Results3 Feb 2023, 6:05PM MedPlus Health Services informs about analyst meet 30 Nov 2022, 3:03PM Medplus Health Servi - Quaterly Results11 Nov 2022, 12:51PM Medplus Health Servi - Quaterly Results11 Nov 2022, 12:51PM Medplus Health Servi - Quaterly Results11 Nov 2022, 12:51PM Medplus Health Services informs about board meeting10 Oct 2022, 5:00PM Medplus Health Services informs about analyst meet 20 Aug 2022, 12:45PM Medplus Health Servi - Quaterly Results10 Aug 2022, 7:47PM Medplus Health Servi - Quaterly Results10 Aug 2022, 7:47PM MedPlus Health Services incorporates wholly-owned subsidiary16 Jul 2022, 10:00AM Medplus Health Servi - Quaterly Results30 May 2022, 5:01PM Medplus Health Servi - Quaterly Results30 May 2022, 5:01PM MedPlus Health Services launches diagnostic centre in Hyderabad3 Mar 2022, 4:57PM

Medplus Health Servi Stock Price Analysis and Quick Research Report. Is Medplus Health Servi an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Medplus Health Servi and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Medplus Health Servi cash from the operating activity was Rs 11.405 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Medplus Health Servi has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Medplus Health Servi , the EPS growth was -0.620188195038497 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Medplus Health Servi has OPM of 2.92390826734479 % which is a bad sign for profitability.
     
  • ROE: Medplus Health Servi have a poor ROE of 0.501213707435484 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Medplus Health Servi is Rs 680.45. One can use valuation calculators of ticker to know if Medplus Health Servi share price is undervalued or overvalued.
Last Updated on:
Brief about Medplus Health Servi

Medplus Health Services Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Medplus Health Services Ltd. is a prominent player in the healthcare sector, committed to providing high-quality services and products to a broad customer base. Established with a vision to make healthcare more accessible and convenient, Medplus has made a significant impact on the industry. In this analysis, we will delve into various aspects of Medplus Health Services Ltd. to provide long-term stock investors with valuable insights and tools for informed decision-making.

 

Medplus Health Services Ltd. - Share Price Analysis

One of the key factors that interests long-term stock investors is the share price of a company. At Medplus Health Services Ltd., our pre-built screening tools enable you to track and analyze the historical performance of the company's shares. With this data, you can identify trends, patterns, and potential entry or exit points. A well-informed investor knows the importance of monitoring share prices closely, and our platform provides the necessary tools to do so.

Medplus Health Services Ltd. - Balance Sheet Examination

 

A thorough examination of Medplus Health Services Ltd.'s balance sheet is essential for investors aiming for the long-term. Our platform offers premium features, including tools such as DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis, which enable you to assess the company's financial health and stability. By scrutinizing assets, liabilities, and equity, investors can gain insights into the company's financial structure and make informed investment decisions.

 

Medplus Health Services Ltd. - Annual Report Insights

 

Medplus Health Services Ltd.'s annual reports are a goldmine of information for investors. These comprehensive reports provide an in-depth look at the company's financial performance, strategies, and future prospects. Our platform offers these reports for download, allowing you to dig deep into the company's operations and understand its long-term vision. By studying annual reports, investors can uncover valuable insights that aid in their decision-making process.

 

Medplus Health Services Ltd. - Dividend Policy

 

For long-term investors seeking stable income streams, Medplus Health Services Ltd.'s dividend policy is of great significance. Dividend payments reflect a company's financial health and commitment to sharing profits with shareholders. On our platform, you can access historical dividend data and perform calculations using our premium tools. This information can assist you in assessing the sustainability and growth potential of dividend payments.

 

Medplus Health Services Ltd. - Quarterly Results Assessment

 

Investors who wish to stay updated on a company's performance often rely on quarterly results. Medplus Health Services Ltd.'s quarterly reports provide valuable insights into the company's short-term performance trends. Our platform offers access to these reports and the ability to perform analyses using tools like DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis. This allows you to evaluate how the company is faring in the short term while considering its long-term potential.

 

Medplus Health Services Ltd. - Stock Price Analysis

 

Monitoring stock prices closely is crucial for long-term investors. Medplus Health Services Ltd.'s historical stock price data, available on our platform, helps you analyze price trends and patterns. Using our pre-built screening tools, you can identify entry and exit points and make well-informed investment decisions based on technical analysis.

 

Medplus Health Services Ltd. - Price Chart Insights

 

Price charts are a fundamental tool for technical analysis. Our platform provides detailed price charts for Medplus Health Services Ltd., enabling long-term investors to study price movements over time. These charts are instrumental in identifying trends and patterns that can inform your investment decisions. Whether you are a novice or an experienced investor, price charts offer valuable insights.

 

Medplus Health Services Ltd. - News Updates

 

Stay informed about the latest developments related to Medplus Health Services Ltd. with our news updates. Our platform aggregates news from various sources, ensuring that you have access to the most current information. Long-term investors benefit from staying in the know, as news can significantly impact investment decisions. We make it easy for you to access news that matters to your investment strategy.

 

Medplus Health Services Ltd. - Conference Call Transcripts

 

Informed investors understand the value of conference call transcripts. These documents provide insights into a company's management discussions, strategies, and future outlook. Medplus Health Services Ltd.'s conference call transcripts are available for download on our platform, allowing you to delve into the details and make well-informed decisions for the long term.

 

Medplus Health Services Ltd. - Investor Presentations

 

Investor presentations offer a comprehensive view of a company's operations and strategies. Accessing Medplus Health Services Ltd.'s investor presentations on our platform provides you with valuable information to assess the company's long-term prospects. These presentations often include key financial data, growth plans, and other essential details.

 

Medplus Health Services Ltd. - Promoters and Shareholders

 

Understanding the company's promoters and shareholders is vital for long-term investors. Our platform provides comprehensive information on Medplus Health Services Ltd.'s key stakeholders. By studying the ownership structure, you can gain insights into the company's governance and strategic direction. This knowledge can be a valuable asset in your investment research.

 

In conclusion, Medplus Health Services Ltd. offers a range of valuable tools and information for long-term stock investors. Whether you are interested in analyzing the share price, balance sheet, annual reports, dividend policy, quarterly results, stock price, price charts, news, concall transcripts, investor presentations, or the company's promoters and shareholders, our platform provides the resources you need to make informed investment decisions. By leveraging our premium features, you can perform in-depth financial analysis and assess the company's long-term potential with confidence.

Read More
X